Abstract
Mobile group II introns are bacterial retrotransposons that combine the activities of an autocatalytic intron RNA (a ribozyme) and an intron-encoded reverse transcriptase to insert site-specifically into DNA. They recognize DNA target sites largely by base pairing of sequences within the intron RNA and achieve high DNA target specificity by using the ribozyme active site to couple correct base pairing to RNA-catalyzed intron integration. Algorithms have been developed to program the DNA target site specificity of several mobile group II introns, allowing them to be made into ‘targetrons.’ Targetrons function for gene targeting in a wide variety of bacteria and typically integrate at efficiencies high enough to be screened easily by colony PCR, without the need for selectable markers. Targetrons have found wide application in microbiological research, enabling gene targeting and genetic engineering of bacteria that had been intractable to other methods. Recently, a thermostable targetron has been developed for use in bacterial thermophiles, and new methods have been developed for using targetrons to position recombinase recognition sites, enabling large-scale genome-editing operations, such as deletions, inversions, insertions, and ‘cut-and-pastes’ (that is, translocation of large DNA segments), in a wide range of bacteria at high efficiency. Using targetrons in eukaryotes presents challenges due to the difficulties of nuclear localization and sub-optimal magnesium concentrations, although supplementation with magnesium can increase integration efficiency, and directed evolution is being employed to overcome these barriers. Finally, spurred by new methods for expressing group II intron reverse transcriptases that yield large amounts of highly active protein, thermostable group II intron reverse transcriptases from bacterial thermophiles are being used as research tools for a variety of applications, including qRT-PCR and next-generation RNA sequencing (RNA-seq). The high processivity and fidelity of group II intron reverse transcriptases along with their novel template-switching activity, which can directly link RNA-seq adaptor sequences to cDNAs during reverse transcription, open new approaches for RNA-seq and the identification and profiling of non-coding RNAs, with potentially wide applications in research and biotechnology.
Highlights
Mobile group II introns are bacterial retrotransposons that perform a remarkable ribozyme-based, site-specific DNA integration reaction (‘retrohoming’) and encode an remarkable reverse transcriptase (RT), both of which have been harnessed for biotechnological applications [1,2,3].Retrohoming occurs by a mechanism in which the group II intron RNA uses its ribozyme activity to insert directly into a DNA strand, where it is reverse transcribed by the intron-encoded RT, yielding a cDNA copy of the intron that is integrated into the genome [4]
Group II intron RTs function in retrohoming by synthesizing a full-length cDNA of the highly structured intron RNA with high processivity and fidelity [8,9,10], properties that are useful for biotechnological applications involving cDNA synthesis, such as qRT-PCR and next-generation RNA sequencing (RNA-seq)
Targetrons Because mobile group II introns recognize their DNA target sites by a combination of base-pairing interactions and site-specific binding of the RT, the target site recognized by the RNP can be modified by finding other sites compatible with RT recognition and changing the Exon-binding site (EBS)/δ sequences of the intron as necessary to match the new site [5]
Summary
Mobile group II introns are bacterial retrotransposons that perform a remarkable ribozyme-based, site-specific DNA integration reaction (‘retrohoming’) and encode an remarkable reverse transcriptase (RT), both of which have been harnessed for biotechnological applications [1,2,3].Retrohoming occurs by a mechanism in which the group II intron RNA uses its ribozyme activity to insert directly into a DNA strand, where it is reverse transcribed by the intron-encoded RT ( referred to as the intron-encoded protein or IEP), yielding a cDNA copy of the intron that is integrated into the genome [4]. The linear group II intron RNA inserted at a target site is reverse-transcribed to yield a cDNA that can be integrated into the genome by non-homologous end joining [36,37].
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have